Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Top Cited Papers
- 1 May 2008
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 9 (5) , 453-461
- https://doi.org/10.1016/s1470-2045(08)70125-6
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Reirradiation Tolerance of the Human BrainInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Distinction Between Recurrent Glioma and Radiation Injury Using Magnetic Resonance Spectroscopy in Combination With Diffusion-Weighted ImagingInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Cerebral radiation necrosis: Incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiformeInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Cerebral Radiation NecrosisThe Neurologist, 2003
- Radiation-induced normal tissue injury: Role of adhesion molecules in leukocyte-endothelial cell interactionsInternational Journal of Cancer, 1999
- Early cystic/necrotic changes after hyperfractionated radiation therapy in children with brain stem gliomas data from the childrens cancer groupCancer, 1993
- Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem gliomaMedical and Pediatric Oncology, 1991
- Reversible Oedema and Necrosis after Irradiation of the Brain Diagnostic Procedures and Clinical ManifestationsActa Oncologica, 1990